Search Results for: US Stem Cell

Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs

CRISPR'd baby opossums.

This edition of The Niche weekly reads has a bit more good news than usual including on stem cell transplants. It’s nice to see positive developments like some recipients of hematopoietic stem cell transplants being able to stay at home afterwards. Also, a reminder. You have until July 31 to enter our stem cell video

Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs Read More »

Translating the FDA’s Q&A on end of stem cell grace period

The Rosetta Stone, The FDA

The FDA grace period for stem cell clinics and others using regenerative medicine products like stem cells is over. It appears the agency is serious about enforcement moving forward. They have released several statements about the end of what they call the “enforcement discretion” period, which just means in English a grace period for marketers

Translating the FDA’s Q&A on end of stem cell grace period Read More »

Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs

making human eggs from stem cells

The paper of the week is from Science on making ovarian follicles and actual eggs from stem cells. It’s just in mice, but this line of work tends to stir people up. We’ll dive into that in a moment. But first some good news. We’re up to 146 subscribers on our stem cell YouTube channel

Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs Read More »

Enter The Niche stem cell videos contest with $100 prize

stem cell videos, YouTube Channel

Who doesn’t like stem cell videos? Some of you already know that we have a stem cell YouTube channel with me, Paul Knoepfler, talking about many important topics on stem cells. The point of the channel is science-based educational outreach to people all over the world. With this in mind, I’ve been thinking it’d be

Enter The Niche stem cell videos contest with $100 prize Read More »

Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR

BioViva CEO Liz Parrish in YouTube video.

Let’s start off today’s recommended reads with the topic of life extension. No controversy there, right? This comes to mind because of a new preprint from BioViva, Liz Parrish, and George Church. I’m hoping to cover this on our Stem Cell Channel on YouTube.  Gene therapy and life extension research The preprint is entitled, “New

Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR Read More »

NIH continuous submission for frequent ad hoc reviewers is quietly dropped

NIH continuous submission, NIH grant review

Something called NIH continuous submission for frequent grant reviewers is now a thing of the past. This is kind of a big deal. It’s got to be a challenge for the NIH to get enough qualified reviewers to serve on study sections as grant reviewers. The recruitment of reviewers just probably got even harder with

NIH continuous submission for frequent ad hoc reviewers is quietly dropped Read More »